{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T18:46:03Z","timestamp":1777574763478,"version":"3.51.4"},"reference-count":107,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000928","name":"Welch Foundation","doi-asserted-by":"publisher","award":["1-0025"],"award-info":[{"award-number":["1-0025"]}],"id":[{"id":"10.13039\/100000928","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL-130253"],"award-info":[{"award-number":["HL-130253"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AR-067294"],"award-info":[{"award-number":["AR-067294"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.yexcr.2021.112844","type":"journal-article","created":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T01:11:59Z","timestamp":1632705119000},"page":"112844","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["CRISPR\/Cas correction of muscular dystrophies"],"prefix":"10.1016","volume":"408","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3384-8887","authenticated-orcid":false,"given":"Yu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2352-5606","authenticated-orcid":false,"given":"Takahiko","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1151-8262","authenticated-orcid":false,"given":"Eric N.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7568-410X","authenticated-orcid":false,"given":"Rhonda","family":"Bassel-Duby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2021.112844_bib1","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1056\/NEJMra1402225","article-title":"Inflammatory muscle diseases","volume":"372","author":"Dalakas","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yexcr.2021.112844_bib2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nrneurol.2017.191","article-title":"Congenital myopathies: disorders of excitation-contraction coupling and muscle contraction","volume":"14","author":"Jungbluth","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.yexcr.2021.112844_bib3","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0140-6736(12)61897-2","article-title":"Muscular dystrophies","volume":"381","author":"Mercuri","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.yexcr.2021.112844_bib4","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.nmd.2019.10.010","article-title":"The 2020 version of the gene table of neuromuscular disorders (nuclear genome)","volume":"29","author":"Benarroch","year":"2019","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.yexcr.2021.112844_bib5","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.132402","article-title":"Pulsed glucocorticoids enhance dystrophic muscle performance through epigenetic-metabolic reprogramming","volume":"4","author":"Quattrocelli","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.yexcr.2021.112844_bib6","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2147\/DDDT.S97635","article-title":"Eteplirsen in the treatment of Duchenne muscular dystrophy","volume":"11","author":"Lim","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.yexcr.2021.112844_bib7","doi-asserted-by":"crossref","first-page":"R102","DOI":"10.1093\/hmg\/ddz128","article-title":"AAV-based gene therapies for the muscular dystrophies","volume":"28","author":"Crudele","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.yexcr.2021.112844_bib8","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nrg3686","article-title":"A guide to genome engineering with programmable nucleases","volume":"15","author":"Kim","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.yexcr.2021.112844_bib9","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1126\/science.aat5011","article-title":"CRISPR-Cas guides the future of genetic engineering","volume":"361","author":"Knott","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.yexcr.2021.112844_bib10","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1126\/science.1138140","article-title":"CRISPR provides acquired resistance against viruses in prokaryotes","volume":"315","author":"Barrangou","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.yexcr.2021.112844_bib11","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.1128\/jb.169.12.5429-5433.1987","article-title":"Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product","volume":"169","author":"Ishino","year":"1987","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.yexcr.2021.112844_bib12","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nrmicro2577","article-title":"Evolution and classification of the CRISPR-Cas systems","volume":"9","author":"Makarova","year":"2011","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.yexcr.2021.112844_bib13","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.yexcr.2021.112844_bib14","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature14299","article-title":"In vivo genome editing using Staphylococcus aureus Cas9","volume":"520","author":"Ran","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2021.112844_bib15","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature14592","article-title":"Engineered CRISPR-Cas9 nucleases with altered PAM specificities","volume":"523","author":"Kleinstiver","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2021.112844_bib16","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1126\/science.aas9129","article-title":"Engineered CRISPR-Cas9 nuclease with expanded targeting space","volume":"361","author":"Nishimasu","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.yexcr.2021.112844_bib17","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1126\/science.aba8853","article-title":"Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants","volume":"368","author":"Walton","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.yexcr.2021.112844_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/nature24268","article-title":"Enhanced proofreading governs CRISPR-Cas9 targeting accuracy","author":"Chen","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2021.112844_bib19","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nature16526","article-title":"High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects","volume":"529","author":"Kleinstiver","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2021.112844_bib20","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.aad5227","article-title":"Rationally engineered Cas9 nucleases with improved specificity","volume":"351","author":"Slaymaker","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.yexcr.2021.112844_bib21","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41576-018-0059-1","article-title":"Base editing: precision chemistry on the genome and transcriptome of living cells","volume":"19","author":"Rees","year":"2018","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.yexcr.2021.112844_bib22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2021.112844_bib23","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nature20565","article-title":"In vivo genome editing via CRISPR\/Cas9 mediated homology-independent targeted integration","volume":"540","author":"Suzuki","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2021.112844_bib24","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/s41586-019-1076-8","article-title":"Precise therapeutic gene correction by a simple nuclease-induced double-stranded break","volume":"568","author":"Iyer","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2021.112844_bib25","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1146\/annurev-genom-090314-025003","article-title":"The pathogenesis and therapy of muscular dystrophies","volume":"16","author":"Guiraud","year":"2015","journal-title":"Annu. Rev. Genom. Hum. Genet."},{"key":"10.1016\/j.yexcr.2021.112844_bib26","first-page":"129","article-title":"Molecular diagnosis of duchenne muscular dystrophy: past, present and future in relation to implementing therapies","volume":"32","author":"Laing","year":"2011","journal-title":"Clin. Biochem. Rev."},{"key":"10.1016\/j.yexcr.2021.112844_bib27","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","article-title":"Dystrophin: the protein product of the Duchenne muscular dystrophy locus","volume":"51","author":"Hoffman","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2021.112844_bib28","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/j.2040-4603.2015.tb00638.x","article-title":"The dystrophin complex: structure, function, and implications for therapy","volume":"5","author":"Gao","year":"2015","journal-title":"Comp. Physiol."},{"key":"10.1016\/j.yexcr.2021.112844_bib29","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/humu.22758","article-title":"The TREAT-NMD DMD Global Database: analysis of more than 7,000 Duchenne muscular dystrophy mutations","volume":"36","author":"Bladen","year":"2015","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.yexcr.2021.112844_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/jpm8040041","article-title":"Multiple exon skipping in the duchenne muscular dystrophy hot spots: prospects and challenges","volume":"8","author":"Echigoya","year":"2018","journal-title":"J. Personalized Med."},{"key":"10.1016\/j.yexcr.2021.112844_bib31","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1073\/pnas.81.4.1189","article-title":"X chromosome-linked muscular dystrophy (mdx) in the mouse","volume":"81","author":"Bulfield","year":"1984","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexcr.2021.112844_bib32","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1126\/science.2662404","article-title":"The molecular basis of muscular dystrophy in the mdx mouse: a point mutation","volume":"244","author":"Sicinski","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.yexcr.2021.112844_bib33","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1073\/pnas.86.4.1292","article-title":"Recovery of induced mutations for X chromosome-linked muscular dystrophy in mice","volume":"86","author":"Chapman","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexcr.2021.112844_bib34","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan8081","article-title":"Single-cut genome editing restores dystrophin expression in a new mouse model of muscular dystrophy","volume":"9","author":"Amoasii","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.yexcr.2021.112844_bib35","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.ymthe.2020.05.024","article-title":"Correction of three prominent mutations in mouse and human models of duchenne muscular dystrophy by single-cut genome editing","volume":"28","author":"Min","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.yexcr.2021.112844_bib36","doi-asserted-by":"crossref","first-page":"eaav4324","DOI":"10.1126\/sciadv.aav4324","article-title":"CRISPR-Cas9 corrects Duchenne muscular dystrophy exon 44 deletion mutations in mice and human cells","volume":"5","author":"Min","year":"2019","journal-title":"Sci Adv"},{"key":"10.1016\/j.yexcr.2021.112844_bib37","doi-asserted-by":"crossref","first-page":"29691","DOI":"10.1073\/pnas.2018391117","article-title":"Degenerative and regenerative pathways underlying Duchenne muscular dystrophy revealed by single-nucleus RNA sequencing","volume":"117","author":"Chemello","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexcr.2021.112844_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008647","article-title":"A duchenne muscular dystrophy gene hot spot mutation in dystrophin-deficient cavalier king charles spaniels is amenable to exon 51 skipping","volume":"5","author":"Walmsley","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.yexcr.2021.112844_bib39","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/BF00688053","article-title":"Progressive muscular dystrophy in a golden retriever dog: light microscope and ultrastructural features at 4 and 8 months","volume":"71","author":"Valentine","year":"1986","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.yexcr.2021.112844_bib40","series-title":"Molecular Characterization of Severe Duchenne-type Muscular Dystrophy in a Family of Rottweiler Dogs, Molecular Mechanism of Neuromuscular Disease","author":"Winand","year":"1994"},{"key":"10.1016\/j.yexcr.2021.112844_bib41","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00335-011-9382-y","article-title":"Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies","volume":"23","author":"Kornegay","year":"2012","journal-title":"Mamm. Genome"},{"key":"10.1016\/j.yexcr.2021.112844_bib42","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0960-8966(99)00011-5","article-title":"Molecular analysis of a spontaneous dystrophin 'knockout' dog","volume":"9","author":"Schatzberg","year":"1999","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.yexcr.2021.112844_bib43","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/labinvest.2010.146","article-title":"An intronic LINE-1 element insertion in the dystrophin gene aborts dystrophin expression and results in Duchenne-like muscular dystrophy in the corgi breed","volume":"91","author":"Smith","year":"2011","journal-title":"Lab. Invest."},{"key":"10.1016\/j.yexcr.2021.112844_bib44","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/age.12266","article-title":"Muscular dystrophy in the Japanese Spitz: an inversion disrupts the DMD and RPGR genes","volume":"46","author":"Atencia-Fernandez","year":"2015","journal-title":"Anim. Genet."},{"key":"10.1016\/j.yexcr.2021.112844_bib45","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1093\/hmg\/ddt287","article-title":"Dystrophin-deficient pigs provide new insights into the hierarchy of physiological derangements of dystrophic muscle","volume":"22","author":"Klymiuk","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.yexcr.2021.112844_bib46","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/ilar\/ilv015","article-title":"Porcine models of muscular dystrophy","volume":"56","author":"Selsby","year":"2015","journal-title":"ILAR J."},{"key":"10.1016\/j.yexcr.2021.112844_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17101668","article-title":"Porcine zygote injection with cas9\/sgRNA results in DMD-modified pig with muscle dystrophy","volume":"17","author":"Yu","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexcr.2021.112844_bib48","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41591-019-0738-2","article-title":"Somatic gene editing ameliorates skeletal and cardiac muscle failure in pig and human models of Duchenne muscular dystrophy","volume":"26","author":"Moretti","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.yexcr.2021.112844_bib49","doi-asserted-by":"crossref","first-page":"14454","DOI":"10.1038\/ncomms14454","article-title":"Muscle-specific CRISPR\/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy","volume":"8","author":"Bengtsson","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yexcr.2021.112844_bib50","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124297","article-title":"AAV CRISPR editing rescues cardiac and muscle function for 18 months in dystrophic mice","volume":"3","author":"Hakim","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.yexcr.2021.112844_bib51","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1126\/science.aad5725","article-title":"Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy","volume":"351","author":"Long","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.yexcr.2021.112844_bib52","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1126\/science.aad5143","article-title":"In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy","volume":"351","author":"Nelson","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.yexcr.2021.112844_bib53","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1126\/science.aad5177","article-title":"In vivo gene editing in dystrophic mouse muscle and muscle stem cells","volume":"351","author":"Tabebordbar","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.yexcr.2021.112844_bib54","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41591-019-0344-3","article-title":"Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy","volume":"25","author":"Nelson","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.yexcr.2021.112844_bib55","doi-asserted-by":"crossref","first-page":"37584","DOI":"10.1038\/srep37584","article-title":"Cas9-catalyzed DNA cleavage generates staggered ends: evidence from molecular dynamics simulations","volume":"5","author":"Zuo","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexcr.2021.112844_bib56","doi-asserted-by":"crossref","first-page":"E2040","DOI":"10.1073\/pnas.1716855115","article-title":"CRISPR\/Cas9 cleavages in budding yeast reveal templated insertions and strand-specific insertion\/deletion profiles","volume":"115","author":"Lemos","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexcr.2021.112844_bib57","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1126\/science.aau1549","article-title":"Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy","volume":"362","author":"Amoasii","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.yexcr.2021.112844_bib58","article-title":"Enhanced CRISPR-Cas9 correction of Duchenne muscular dystrophy in mice by a self-complementary AAV delivery system","volume":"6","author":"Zhang","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.yexcr.2021.112844_bib59","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/nbt.4148","article-title":"Adenine base editing in mouse embryos and an adult mouse model of Duchenne muscular dystrophy","volume":"36","author":"Ryu","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.yexcr.2021.112844_bib60","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1093\/hmg\/2.12.2037","article-title":"FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit","volume":"2","author":"van Deutekom","year":"1993","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.yexcr.2021.112844_bib61","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ng.2454","article-title":"Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2","volume":"44","author":"Lemmers","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.yexcr.2021.112844_bib62","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/s41467-017-00730-1","article-title":"Muscle pathology from stochastic low level DUX4 expression in an FSHD mouse model","volume":"8","author":"Bosnakovski","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yexcr.2021.112844_bib63","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.celrep.2014.07.056","article-title":"Dominant lethal pathologies in male mice engineered to contain an X-linked DUX4 transgene","volume":"8","author":"Dandapat","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.yexcr.2021.112844_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003415","article-title":"Intrinsic epigenetic regulation of the D4Z4 macrosatellite repeat in a transgenic mouse model for FSHD","volume":"9","author":"Krom","year":"2013","journal-title":"PLoS Genet."},{"key":"10.1016\/j.yexcr.2021.112844_bib65","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/mt.2015.200","article-title":"CRISPR\/dCas9-mediated transcriptional inhibition ameliorates the epigenetic dysregulation at D4Z4 and represses DUX4-fl in FSH muscular dystrophy","volume":"24","author":"Himeda","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.yexcr.2021.112844_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/jpm11010007","article-title":"Gene editing targeting the DUX4 polyadenylation signal: a therapy for FSHD?","volume":"11","author":"Joubert","year":"2020","journal-title":"J. Personalized Med."},{"key":"10.1016\/j.yexcr.2021.112844_bib67","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S1474-4422(12)70204-1","article-title":"The myotonic dystrophies: molecular, clinical, and therapeutic challenges","volume":"11","author":"Udd","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.yexcr.2021.112844_bib68","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1093\/hmg\/10.23.2717","article-title":"Mice transgenic for the human myotonic dystrophy region with expanded CTG repeats display muscular and brain abnormalities","volume":"10","author":"Seznec","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.yexcr.2021.112844_bib69","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1126\/science.289.5485.1769","article-title":"Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat","volume":"289","author":"Mankodi","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.yexcr.2021.112844_bib70","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1016\/j.ymthe.2018.09.003","article-title":"Therapeutic genome editing for myotonic dystrophy type 1 using CRISPR\/Cas9","volume":"26","author":"Wang","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.yexcr.2021.112844_bib71","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.molcel.2017.09.033","article-title":"Impeding transcription of expanded microsatellite repeats by deactivated Cas9","volume":"68","author":"Pinto","year":"2017","journal-title":"Mol. Cell."},{"key":"10.1016\/j.yexcr.2021.112844_bib72","doi-asserted-by":"crossref","DOI":"10.1038\/s41551-020-00607-7","article-title":"The sustained expression of Cas9 targeting toxic RNAs reverses disease phenotypes in mouse models of myotonic dystrophy type 1","author":"Batra","year":"2020","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.yexcr.2021.112844_bib73","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.ymthe.2019.05.021","article-title":"Genome editing of expanded CTG repeats within the human DMPK gene reduces nuclear RNA foci in the muscle of DM1 mice","volume":"27","author":"Lo Scrudato","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.yexcr.2021.112844_bib74","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/1689","article-title":"A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B","volume":"20","author":"Bashir","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.yexcr.2021.112844_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039233","article-title":"Homologous recombination mediates functional recovery of dysferlin deficiency following AAV5 gene transfer","volume":"7","author":"Grose","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.yexcr.2021.112844_bib76","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1093\/hmg\/ddq065","article-title":"Efficient recovery of dysferlin deficiency by dual adeno-associated vector-mediated gene transfer","volume":"19","author":"Lostal","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.yexcr.2021.112844_bib77","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/acn3.172","article-title":"AAV.Dysferlin overlap vectors restore function in dysferlinopathy animal models","volume":"2","author":"Sondergaard","year":"2015","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.yexcr.2021.112844_bib78","first-page":"1","article-title":"Genetic basis of limb-girdle muscular dystrophies: the 2014 update","volume":"33","author":"Nigro","year":"2014","journal-title":"Acta Myol."},{"key":"10.1016\/j.yexcr.2021.112844_bib79","series-title":"GeneReviews(R)","article-title":"Limb-girdle muscular dystrophy overview","author":"Pegoraro","year":"1993"},{"key":"10.1016\/j.yexcr.2021.112844_bib80","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1083\/jcb.142.5.1279","article-title":"Gamma-sarcoglycan deficiency leads to muscle membrane defects and apoptosis independent of dystrophin","volume":"142","author":"Hack","year":"1998","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.yexcr.2021.112844_bib81","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1083\/jcb.142.6.1461","article-title":"Progressive muscular dystrophy in alpha-sarcoglycan-deficient mice","volume":"142","author":"Duclos","year":"1998","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.yexcr.2021.112844_bib82","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1097-2765(00)80410-4","article-title":"Disruption of the beta-sarcoglycan gene reveals pathogenetic complexity of limb-girdle muscular dystrophy type 2E","volume":"5","author":"Durbeej","year":"2000","journal-title":"Mol. Cell."},{"key":"10.1016\/j.yexcr.2021.112844_bib83","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1093\/hmg\/8.9.1589","article-title":"Loss of the sarcoglycan complex and sarcospan leads to muscular dystrophy in beta-sarcoglycan-deficient mice","volume":"8","author":"Araishi","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.yexcr.2021.112844_bib84","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0092-8674(00)81975-3","article-title":"Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy","volume":"98","author":"Coral-Vazquez","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2021.112844_bib85","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.nmd.2010.09.007","article-title":"Magnetic resonance imaging assessment of cardiac dysfunction in delta-sarcoglycan null mice","volume":"21","author":"Wansapura","year":"2011","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.yexcr.2021.112844_bib86","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13395-017-0131-0","article-title":"Exome sequencing reveals independent SGCD deletions causing limb girdle muscular dystrophy in Boston terriers","volume":"7","author":"Cox","year":"2017","journal-title":"Skeletal Muscle"},{"key":"10.1016\/j.yexcr.2021.112844_bib87","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13395-020-00257-y","article-title":"Sarcoglycan A mutation in miniature dachshund dogs causes limb-girdle muscular dystrophy 2D","volume":"11","author":"Mickelson","year":"2021","journal-title":"Skeletal Muscle"},{"key":"10.1016\/j.yexcr.2021.112844_bib88","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13395-016-0103-9","article-title":"Direct reprogramming of urine-derived cells with inducible MyoD for modeling human muscle disease","volume":"6","author":"Kim","year":"2016","journal-title":"Skeletal Muscle"},{"key":"10.1016\/j.yexcr.2021.112844_bib89","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/mt.2016.40","article-title":"Precise correction of disease mutations in induced pluripotent stem cells derived from patients with limb girdle muscular dystrophy","volume":"24","author":"Turan","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.yexcr.2021.112844_bib90","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193289","article-title":"A dystrophic Duchenne mouse model for testing human antisense oligonucleotides","volume":"13","author":"Veltrop","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.yexcr.2021.112844_bib91","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3233\/JND-170218","article-title":"Creation of a novel humanized dystrophic mouse model of duchenne muscular dystrophy and application of a CRISPR\/Cas9 gene editing therapy","volume":"4","author":"Young","year":"2017","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.yexcr.2021.112844_bib92","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0244215","article-title":"Detailed genetic and functional analysis of the hDMDdel52\/mdx mouse model","volume":"15","author":"Yavas","year":"2020","journal-title":"PloS One"},{"key":"10.1016\/j.yexcr.2021.112844_bib93","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1212\/WNL.39.8.1011","article-title":"Improved diagnosis of Becker muscular dystrophy by dystrophin testing","volume":"39","author":"Hoffman","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/j.yexcr.2021.112844_bib94","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/ana.25951","article-title":"Very low residual dystrophin quantity is associated with milder dystrophinopathy","volume":"89","author":"de Feraudy","year":"2021","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.yexcr.2021.112844_bib95","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.omtm.2021.05.014","article-title":"A consolidated AAV system for single-cut CRISPR correction of a common Duchenne muscular dystrophy mutation","volume":"22","author":"Zhang","year":"2021","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.yexcr.2021.112844_bib96","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nbt.2623","article-title":"High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells","volume":"31","author":"Fu","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.yexcr.2021.112844_bib97","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nbt.2647","article-title":"DNA targeting specificity of RNA-guided Cas9 nucleases","volume":"31","author":"Hsu","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.yexcr.2021.112844_bib98","doi-asserted-by":"crossref","first-page":"7473","DOI":"10.1093\/nar\/gku402","article-title":"CRISPR\/Cas9 systems have off-target activity with insertions or deletions between target DNA and guide RNA sequences","volume":"42","author":"Lin","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.yexcr.2021.112844_bib99","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1152\/physrev.00043.2011","article-title":"Satellite cells and the muscle stem cell niche","volume":"93","author":"Yin","year":"2013","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.yexcr.2021.112844_bib100","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.cell.2015.05.026","article-title":"Dynamics of cell generation and turnover in the human heart","volume":"161","author":"Bergmann","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2021.112844_bib101","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1126\/science.1164680","article-title":"Evidence for cardiomyocyte renewal in humans","volume":"324","author":"Bergmann","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.yexcr.2021.112844_bib102","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.ymthe.2019.06.012","article-title":"AAV9 edits muscle stem cells in normal and dystrophic adult mice","volume":"27","author":"Nance","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.yexcr.2021.112844_bib103","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.omtm.2020.09.016","article-title":"In vivo gene editing of muscle stem cells with adeno-associated viral vectors in a mouse model of duchenne muscular dystrophy","volume":"19","author":"Kwon","year":"2020","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.yexcr.2021.112844_bib104","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.ymthe.2019.05.001","article-title":"Life-long AAV-mediated CRISPR genome editing in dystrophic heart improves cardiomyopathy without causing serious lesions in mdx mice","volume":"27","author":"Xu","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.yexcr.2021.112844_bib105","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1161\/CIRCRESAHA.117.310996","article-title":"In vivo genome editing restores dystrophin expression and cardiac function in dystrophic mice","volume":"121","author":"El Refaey","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.yexcr.2021.112844_bib106","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.ymthe.2018.03.018","article-title":"Functional rescue of dystrophin deficiency in mice caused by frameshift mutations using Campylobacter jejuni Cas9","volume":"26","author":"Koo","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.yexcr.2021.112844_bib107","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1016\/j.ymthe.2018.08.010","article-title":"CRISPR-induced deletion with SaCas9 restores dystrophin expression in dystrophic models in vitro and in vivo","volume":"26","author":"Duchene","year":"2018","journal-title":"Mol. Ther."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482721003980?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482721003980?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T19:23:18Z","timestamp":1777404198000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482721003980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":107,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0014482721003980"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2021.112844","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CRISPR\/Cas correction of muscular dystrophies","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2021.112844","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112844"}}